automation

cell therapy oncology cancer CAR-T cells
Manufacturing

Cellares, Ori dominate automated cell therapy production: report

The bulk of the field’s raised capital (81%) is held by Cellares and Ori Biotech, Tracxn said in a new report.
Fraiser Kansteiner Jun 18, 2026 10:10am
Eli Lilly Concord NC Lilly plant

How Lilly is tapping automation, robots and local talent in NC

Jun 26, 2025 8:50am
Takasaki Japan

Kyowa Kirin wraps up build out of $118M biologics plant

Apr 11, 2025 10:00am
Advanced manufacturing manufacturing technology advanced technology

Cellares' cell therapy production tech wins key FDA designation

Apr 2, 2025 9:40am
Multiply Labs robotics cell therapy automated cell therapy manufacturing

Legend strikes cell therapy automation pact with Multiply Labs

Sep 24, 2024 9:00am
Ori IRO Charles River Jason Foster Matt Hewitt

Charles River looks to help bring Ori's CGT platform forward

Sep 18, 2024 8:01am